Alumis to Present at Leerink’s 2025 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., March 10, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will participate in a fireside chat at Leerink’s 2025 Global Healthcare Conference on Tuesday, March 11, 2025 at 10:40 am ET.

A live webcast will be available on the Alumis website in the “Investors” section under the “Events” page.

About Alumis
Alumis is a clinical-stage biopharmaceutical company developing …

Full story available on Benzinga.com